Valuation: Imexpharm Corporation

Market Cap 5,406B 206M 179M 166M 153M 288M 19.62B 293M 1.96B 769M 9.77B 772M 755M 32.76B P/E 2026 *
15.2x
P/E 2027 * 14x
Enterprise Value 5,406B 206M 179M 166M 153M 288M 19.62B 293M 1.96B 769M 9.77B 772M 755M 32.76B EV / Sales 2026 *
2.03x
EV / Sales 2027 * 1.88x
Free-Float
6.42%
Yield 2026 *
2.85%
Yield 2027 * 2.85%
1 day-2.50%
1 week+0.29%
1 month-16.03%
3 months-30.91%
6 months-35.24%
Current year-33.14%
1 week 32,650
Extreme 32650
36,550
1 month 32,650
Extreme 32650
43,150
Current year 32,650
Extreme 32650
57,000
1 year 32,650
Extreme 32650
57,000
3 years 23,681.82
Extreme 23681.8182
57,000
5 years 18,831.17
Extreme 18831.1688
57,000
10 years 12,793.53
Extreme 12793.5306
57,000
Manager TitleAgeSince
Chief Executive Officer 74 01/08/2001
Director of Finance/CFO 52 18/01/2024
Chief Operating Officer 47 -
Director TitleAgeSince
Chairman 74 01/01/1984
Director/Board Member 50 28/04/2018
Director/Board Member - 30/05/2020
Date Insider Type Main position Quantity % Market Cap.
9/26/22 A Buy

Chief Executive Officer

140,000 0.2100%
7/20/22 A Sell

Chief Executive Officer

100,000 0.1500%
4/1/22 A Fiscal year

Chairman

50,000 0.0750%
Change 5-day change 1-year change 3-year change Capi.($)
-2.50%+0.29%-33.40%+16.16% 206M
-0.53%-3.95%+50.70%+153.56% 1,024B
+0.21%-2.68%+53.20%+51.79% 618B
-2.51%-3.25%+28.54%+68.94% 443B
+0.06%-0.42%+37.53%+30.67% 349B
-0.69%-0.30%+13.76%+12.83% 264B
-7.37%-4.40%-0.74%-44.28% 209B
-0.64%+2.43%+29.74%+65.93% 208B
-0.82%+0.70%+15.05%+72.05% 162B
+0.40%+1.92%+6.47%-29.77% 143B
Average -1.44%-1.06%+20.09%+39.79% 341.91B
Weighted average by Cap. -1.00%-2.02%+36.14%+71.90%

Financials

2026 *2027 *
Net sales 2,659B 101M 87.9M 81.82M 75.12M 142M 9.65B 144M 964M 379M 4.81B 380M 371M 16.11B 2,881B 110M 95.24M 88.65M 81.39M 154M 10.46B 156M 1.04B 410M 5.21B 411M 402M 17.46B
Net income 394B 14.98M 13.02M 12.12M 11.13M 21.02M 1.43B 21.35M 143M 56.09M 712M 56.27M 55.04M 2.39B 428B 16.28M 14.15M 13.17M 12.09M 22.83M 1.55B 23.19M 155M 60.93M 774M 61.13M 59.78M 2.59B
Net Debt - -
Logo Imexpharm Corporation
Imexpharm Corporation is a Vietnam-based company engaged in the pharmaceutical industry. The Company manufactures, imports, exports and trades pharmaceutical products, antiseptics, traditional medicine, medical equipment and supplies, cosmetics, supplemental food and drinks. It is also involved in the provision of packaging services and warehousing services for pharmaceutical storage purposes. In addition, the Company is involved in medicinal herb cultivation.
Employees
1,438
Date Price Change Volume
31/07/26 ₫35,100.00 -2.50% 14,190
30/07/26 ₫36,000.00 +0.84% 8,294
29/07/26 ₫35,700.00 +2.00% 7,894
28/07/26 ₫35,000.00 -.--% 8,610
27/07/26 ₫35,000.00 -.--% 12,818
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
35,100.00VND
Average target price
56,000.00VND
Spread / Average Target
+59.54%

Annual profits - Rate of surprise